BRIEF — Biomea Fusion Announces Phase 1 Results For Bmf — 650, Its Investigational Next — Generation Oral Small Molecule Glp — 1 Receptor Agonist
Oct 13 (Reuters) — Biomea Fusion, Inc.: Biomea Fusion Announces Phase 1 Results For Bmf-650, Its Investigational Next-generation Oral Small Molecule Glp-1 Receptor Agonist Biomea Fusion - No Severe Or Serious Adverse Events Reported In Bmf-650 Phase 1 Mad Participants Biomea Fusion - All Adverse Events In Five Mad Coho